CN103041344A - Drug for treating osteoporosis - Google Patents
Drug for treating osteoporosis Download PDFInfo
- Publication number
- CN103041344A CN103041344A CN 201210595553 CN201210595553A CN103041344A CN 103041344 A CN103041344 A CN 103041344A CN 201210595553 CN201210595553 CN 201210595553 CN 201210595553 A CN201210595553 A CN 201210595553A CN 103041344 A CN103041344 A CN 103041344A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- drug
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating osteoporosis, which is prepared by the following active ingredients in parts by weight: 4-8 parts of rhizoma zingiberis, 6-10 parts of rabdosia rubescens, 1-5 parts of liquorice, 1-3 parts of euphorbia kansui, 1-5 parts of folium onychii, 3-6 parts of rhizoma arisaematis, 1-5 parts of acanthopanax, 10-15 parts of radix saposhnikoviae, 3-7 parts of Chinese pulsatilla roots, 10-20 parts of indian iphigenia bulb, 3-6 parts of radix stemonae, 10-15 parts of cinnamomum cassia, 4-8 parts of fritillary bulb, 1-5 parts of cimicifugae foetidae, 1-3 parts of radix ophiopogonis and 3-7 parts of semen cassiae. The drug for treating the osteoporosis adopts natural medicines, and therefore has the advantages of quick effectiveness, good curative effect and no nontoxic or side effects.
Description
Technical field
The present invention relates to the orthopaedics field, specifically, relate to a kind of osteoporotic medicament for the treatment of.
Background technology
Osteoporosis is a kind of systemic osteopathia.With chronic lumbar and back pain, very then deformity, fracture are a kind of general bone amount minimizing property disease of main manifestations.Osteoporosis is impaired with the osseous tissue microstructure, and bone ore deposit composition and bone matrix equal proportion constantly reduce, the sclerotin attenuation, and bone trabecula quantity reduces, the disease of a kind of general bone metabolism obstacle that the increase of bone fragility and risk of fractures degree raise.At present, osteoporosis just is being multiple trend.
Summary of the invention
The purpose of this invention is to provide a kind of osteoporotic medicament for the treatment of.
In order to realize purpose of the present invention, the invention provides a kind of osteoporotic medicament for the treatment of, it is to be made by weight by following bulk drugs: 3～7 parts of 4～8 parts of Rhizoma Zingiberiss, 6～10 parts of Rabdosia rubescens, 1～5 part in Radix Glycyrrhizae, 1～3 part of Radix Kansui, 1～5 part of Herba Pteridis creticae, 3～6 parts of Rhizoma Arisaematiss, 1～5 part of Radix Et Caulis Acanthopanacis Senticosi, 10～15 parts of Radix Saposhnikoviaes, 3～7 parts of the Radix Pulsatillaes, 10～20 parts of Pseudobulbus Cremastrae Seu Pleioness, 3～6 parts of the Radixs Stemonae, 10～15 parts of Cortex Cinnamomis, 4～8 parts of Bulbus Fritillariae Pallidifloraes, 1～5 part of Rhizoma Cimicifugae, 1～3 part of Radix Ophiopogonis and Semen Cassiaes.
Preferably, it is to be made by weight by following bulk drugs: 4 parts of 5 parts of Rhizoma Zingiberiss, 7 parts of Rabdosia rubescens, 2 parts in Radix Glycyrrhizae, 2 parts of Radix Kansuis, 3 parts of Herba Pteridis creticae, 4 parts of Rhizoma Arisaematiss, 3 parts of Radix Et Caulis Acanthopanacis Senticosis, 11 parts of Radix Saposhnikoviaes, 4 parts of the Radix Pulsatillaes, 17 parts of Pseudobulbus Cremastrae Seu Pleioness, 4 parts of the Radixs Stemonae, 13 parts of Cortex Cinnamomis, 6 parts of Bulbus Fritillariae Pallidifloraes, 3 parts of Rhizoma Cimicifugaes, 2 parts of Radix Ophiopogonis and Semen Cassiaes.
Preferably, described medicament is tablet, dispersible tablet, instant, powder or granule.
Use natural drug in the osteoporotic medicament for the treatment of of the present invention, so it have advantages of instant effect, good effect, has no side effect.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Rhizoma Zingiberis 50 gram, Rabdosia rubescens 70 grams, Radix Glycyrrhizae 20 grams, Radix Kansui 20 grams, Herba Pteridis creticae 30 grams, Rhizoma Arisaematis 40 grams, Radix Et Caulis Acanthopanacis Senticosi 30 grams, Radix Saposhnikoviae 110 grams, the Radix Pulsatillae 40 grams, Pseudobulbus Cremastrae Seu Pleiones 170 grams, the Radix Stemonae 40 grams, Cortex Cinnamomi 130 grams, Bulbus Fritillariae Pallidiflorae 60 grams, Rhizoma Cimicifugae 30 grams, Radix Ophiopogonis 20 gram and Semen Cassiae 40 grams, pulverize, cross 100 mesh sieves, then add sucrose 250 grams, mixing is packed in 100 bags and be get final product.
Experimental example
The diagnostic criteria cardinal symptom: osteodynia, lumbar and back pain, the lower limb knees soreness is easily sent out fracture, can be with talalgia, night or row's myenteron spasm is arranged.X-ray is acted normally or Bone density reduction, cortical bone attenuation, bone trabecula reduce to attenuate or have the breast lumbar vertebral body to be concave-concave shape or the place ahead and be wedge shape and change.Bone mineral density T 〉=-2.5.
Close 80 routine sufferers of osteoporosis face of the standard of stating of selector, male 40 examples, women 40 examples, the mean age is 58 years old.
Treat with the powder that makes among the embodiment 1, wherein one day 2 times, each one bag, treating 30 days is a course for the treatment of, treats continuously 2 courses for the treatment of.
Criterion of therapeutical effect (according to the Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying). Beijing: the Chinese Medicine science and technology .2002:357 of publishing house formulates) and produce effects: lumbago and backache, the symptoms such as local pain disappear substantially, and the walking lumbago and backache disappears; Effectively: the above-mentioned symptom elimination, walking pain alleviates to some extent; Invalid: above-mentioned symptom is without obvious improvement.
Process has the observation of 2 courses for the treatment of, 80 routine patients' lumbago and backache, and the symptoms such as local pain disappear substantially, and the walking lumbago and backache disappears, and all meets the treatment standard of produce effects, and do not observe obvious untoward reaction during whole treatment.
Claims (3)
1. treat osteoporotic medicament for one kind, it is characterized in that, it is to be made by weight by following bulk drugs: 3～7 parts of 4～8 parts of Rhizoma Zingiberiss, 6～10 parts of Rabdosia rubescens, 1～5 part in Radix Glycyrrhizae, 1～3 part of Radix Kansui, 1～5 part of Herba Pteridis creticae, 3～6 parts of Rhizoma Arisaematiss, 1～5 part of Radix Et Caulis Acanthopanacis Senticosi, 10～15 parts of Radix Saposhnikoviaes, 3～7 parts of the Radix Pulsatillaes, 10～20 parts of Pseudobulbus Cremastrae Seu Pleioness, 3～6 parts of the Radixs Stemonae, 10～15 parts of Cortex Cinnamomis, 4～8 parts of Bulbus Fritillariae Pallidifloraes, 1～5 part of Rhizoma Cimicifugae, 1～3 part of Radix Ophiopogonis and Semen Cassiaes.
2. the osteoporotic medicament for the treatment of according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 4 parts of 5 parts of Rhizoma Zingiberiss, 7 parts of Rabdosia rubescens, 2 parts in Radix Glycyrrhizae, 2 parts of Radix Kansuis, 3 parts of Herba Pteridis creticae, 4 parts of Rhizoma Arisaematiss, 3 parts of Radix Et Caulis Acanthopanacis Senticosis, 11 parts of Radix Saposhnikoviaes, 4 parts of the Radix Pulsatillaes, 17 parts of Pseudobulbus Cremastrae Seu Pleioness, 4 parts of the Radixs Stemonae, 13 parts of Cortex Cinnamomis, 6 parts of Bulbus Fritillariae Pallidifloraes, 3 parts of Rhizoma Cimicifugaes, 2 parts of Radix Ophiopogonis and Semen Cassiaes.
3. the osteoporotic medicament for the treatment of according to claim 1 and 2 is characterized in that, described medicament is tablet, dispersible tablet, instant, powder or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210595553 CN103041344A (en) | 2012-12-31 | 2012-12-31 | Drug for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210595553 CN103041344A (en) | 2012-12-31 | 2012-12-31 | Drug for treating osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103041344A true CN103041344A (en) | 2013-04-17 |
Family
ID=48054355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210595553 Pending CN103041344A (en) | 2012-12-31 | 2012-12-31 | Drug for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041344A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105906682A (en) * | 2016-04-23 | 2016-08-31 | 陈斌 | Butenafine hydrochloride pharmaceutical composition and application thereof in biomedicines |
-
2012
- 2012-12-31 CN CN 201210595553 patent/CN103041344A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105906682A (en) * | 2016-04-23 | 2016-08-31 | 陈斌 | Butenafine hydrochloride pharmaceutical composition and application thereof in biomedicines |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN102327420B (en) | Chinese medicinal composition for setting bones and replenishing muscles and ligaments | |
| CN101703692A (en) | Chinese medicinal preparation for treating bone fracture and preparation method thereof | |
| CN102940853A (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN102319332A (en) | Musk bone reunion Chinese medicinal composition | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN104288631A (en) | Medicine composition for treating colon cancer and preparation method thereof | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN103463582B (en) | A kind of pharmaceutical composition treating pelvic inflammatory disease and its production and use | |
| CN104383242A (en) | Medicament composition for treating ovarian cyst and preparation method thereof | |
| CN102657751B (en) | Medicament for treating osteoporosis | |
| CN103041344A (en) | Drug for treating osteoporosis | |
| CN103127375A (en) | Chinese materia medica preparation for treating osteoporosis | |
| CN103463304B (en) | One treats arthroncus of knee Chinese medicine | |
| CN102657771A (en) | Medicament for osteoporosis treatment | |
| CN103083638B (en) | Medicament for treating osteoporosis | |
| CN102600366B (en) | Medicament for treating osteoporosis, osteoproliferation and renal failure | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN101088534B (en) | Medicine composition for treating bone necrosis and its preparation process | |
| CN101732408B (en) | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof | |
| CN102362937B (en) | Medicinal composition for treating rheumatic aches and pains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130417 |